MUCINEX 12HR COLD & FEVER MULTI-SYMPTOM
Launchdextromethorphan hydrobromide; guaifenesin; naproxen sodium
NDAORALTABLET, EXTENDED RELEASE
Approved
Dec 2025
Lifecycle
Launch
Competitive Pressure
30/100
Data completeness
2/8 — Basic
Drug data last refreshed 3d ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Mucinex 12HR Cold & Fever Multi-Symptom is an oral extended-release tablet combining dextromethorphan (cough suppressant), guaifenesin (expectorant), and naproxen sodium (NSAID/fever reducer) for symptomatic relief of cold and flu symptoms. This is a fixed-dose combination product targeting over-the-counter consumers seeking multi-symptom cold relief with extended 12-hour dosing convenience.
Launch10.4 years to LOE
Early-stage launch with moderate competitive pressure (30% intensity) suggests commercial teams are actively building market presence and establishing distribution networks.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Roles on this product focus on commercial execution in the competitive OTC cold/flu segment, including brand building, retail distribution, and consumer messaging. Career growth depends on successfully gaining market share in a mature category rather than innovation pipeline advancement.
Brand ManagerField Sales Representative
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.